Prosecution Insights
Last updated: October 02, 2026

Examiner: RODRIGUEZ, CRIS LOIREN

Tech Center 3700 • Art Units: 3732 3772 3783

This examiner grants 26% of resolved cases

Analysis

Cris Loiren Rodriguez, in Tech Center 3700 and Art Unit 3732, has 205 resolved cases. The allowance rate is 26.3 percent, which indicates a difficult examination process. The median days to allowance is 1221, suggesting a timeline of over three years for those applications that do eventually reach a grant. This combination of a low success rate and long pendency makes for a challenging environment for applicants in this technology area.

The interview lift is 11.4 percent. While an interview provides some benefit over the 26.3 percent base rate, the 1221-day median pendency suggests that even with verbal advocacy, the path to allowance remains difficult. For the 205 resolved cases, the data indicates that while interviews are helpful, they may not be enough to overcome all the hurdles in Art Unit 3732. Practitioners should use interviews strategically to clarify the examiner's objections but also focus on written responses. In Tech Center 3700, this examiner's metrics highlight the need for a persistent prosecution strategy to improve the odds of a successful outcome.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

26.3%
Allow Rate
-43.7% vs TC avg
224
Total Applications
+11.4%
Interview Lift
1221
Avg Prosecution Days
Based on 205 resolved cases, 2023–2026

Rejection Statute Breakdown

1.6%
§101 Eligibility
24.8%
§102 Novelty
46.4%
§103 Obviousness
24.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18571825 COMPOSITIONS OF EXTENDED RELEASE COATINGS AND METHODS FOR APPLYING EXTENDED RELEASE COATINGS Non-Final OA Eli Lilly and Company
18693711 INTERLOCKED SENSOR ASSEMBLY FOR INFUSION SYSTEM Non-Final OA CareFusion 303, Inc.
18158630 BALLOON CATHETER Final Rejection ASAHI INTECC CO., LTD.
18585182 Auto-Injector With Assembly and Alignment Features Non-Final OA Becton, Dickinson and Company
18545067 FILLABLE MEDICAMENT DELIVERY DEVICE Non-Final OA Becton, Dickinson and Company
18694104 Electronics Device with Battery Life Optimisation Provided for a drug delivery device or a drug delivery add-on device Non-Final OA Sanofi
18313788 DEVICE AND METHOD FOR THE METERED DISPENSING OF A LIQUID Non-Final OA Heraeus Medical GmbH
17506145 BODY CONFORMING WEARABLE DEVICE FOR PROVIDING OUTPUT AND INPUT FOR A DRUG DELIVERY SYSTEM Final Rejection Insulet Corporation
19171829 ACTIVATION SYSTEM FOR A SUPPLEMENTAL DEVICE ATTACHED TO A MEDICAMENT DELIVERY DEVICE Final Rejection SHL MEDICAL AG
18350292 NEEDLE-FREE INJECTOR BASED ON UNDERWATER DISCHARGE USING SHOCK WAVE Final Rejection JEISYS MEDICAL INC.
18703014 CLOSURE PIECE FOR A MEDICAL HOLLOW BODY, MEDICAL HOLLOW BODY HAVING SUCH A CLOSURE PIECE, AND METHOD FOR PRODUCING SUCH A CLOSURE PIECE Non-Final OA VETTER PHARMA-FERTIGUNG GMBH & CO. KG
18466362 SYRINGE CONNECTOR Final Rejection KABUSHIKI KAISHA TOP

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month